Avalon BioVentures I, LP insider trades
Avalon BioVentures I, LP has filed 3 Form 4s with the SEC that we hold, all for Janux Therapeutics, Inc. (JANX), as 10% owner. Across all of them we count 0 purchases worth $0 and 27 sales worth $45.8M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 161,356 shares of Janux Therapeutics, Inc. worth $7.6M, dated 2024-09-12. The first filing on our record is dated 2024-09-10 and the latest 2024-09-30.
Janux Therapeutics, Inc. (JANX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-06 | S, sale reported on Form 4 | 108,365 | $4.6M | 2024-09-10 |
| 2024-09-06 | S, sale reported on Form 4 | 20,991 | $881.6K | 2024-09-10 |
| 2024-09-06 | S, sale reported on Form 4 | 110,644 | $4.6M | 2024-09-10 |
| 2024-09-09 | S, sale reported on Form 4 | 2,182 | $92.4K | 2024-09-10 |
| 2024-09-10 | S, sale reported on Form 4 | 11,319 | $522.1K | 2024-09-12 |
| 2024-09-10 | S, sale reported on Form 4 | 2,193 | $101.2K | 2024-09-12 |
| 2024-09-10 | S, sale reported on Form 4 | 11,557 | $533.1K | 2024-09-12 |
| 2024-09-10 | S, sale reported on Form 4 | 34,326 | $1.6M | 2024-09-12 |
| 2024-09-10 | S, sale reported on Form 4 | 6,649 | $310.2K | 2024-09-12 |
| 2024-09-10 | S, sale reported on Form 4 | 35,047 | $1.6M | 2024-09-12 |
| 2024-09-12 | S, sale reported on Form 4 | 30,613 | $1.4M | 2024-09-12 |
| 2024-09-12 | S, sale reported on Form 4 | 161,356 | $7.6M | 2024-09-12 |
| 2024-09-12 | S, sale reported on Form 4 | 158,031 | $7.4M | 2024-09-12 |
| 2024-09-26 | S, sale reported on Form 4 | 49,497 | $2.3M | 2024-09-30 |
| 2024-09-26 | S, sale reported on Form 4 | 9,592 | $448.7K | 2024-09-30 |
| 2024-09-26 | S, sale reported on Form 4 | 50,539 | $2.4M | 2024-09-30 |
| 2024-09-26 | S, sale reported on Form 4 | 40,803 | $1.9M | 2024-09-30 |
| 2024-09-26 | S, sale reported on Form 4 | 7,908 | $377.8K | 2024-09-30 |
| 2024-09-26 | S, sale reported on Form 4 | 41,661 | $2.0M | 2024-09-30 |
| 2024-09-27 | S, sale reported on Form 4 | 8,894 | $412.9K | 2024-09-30 |
| 2024-09-27 | S, sale reported on Form 4 | 45,894 | $2.1M | 2024-09-30 |
| 2024-09-27 | S, sale reported on Form 4 | 46,861 | $2.2M | 2024-09-30 |
| 2024-09-27 | S, sale reported on Form 4 | 1,511 | $72.1K | 2024-09-30 |
| 2024-09-27 | S, sale reported on Form 4 | 293 | $14.0K | 2024-09-30 |
| 2024-09-27 | S, sale reported on Form 4 | 1,542 | $73.6K | 2024-09-30 |
| 2024-09-27 | S, sale reported on Form 4 | 1,826 | $84.3K | 2024-09-30 |
| 2024-09-30 | S, sale reported on Form 4 | 958 | $44.3K | 2024-09-30 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1873935) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms